RxDoctor Payments Data

Adam Strehle, DO

Family Medicine · Creighton, NENPI 1689055394

Payments from drug & device makers

$162in general payments, 2019–2025

Across 10 payments — averaging $16.19 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Lilly USA, LLC$42
  • Conetic Solutions, Inc.$21
  • Boston Scientific$21
  • Otsuka America Pharmaceutical, Inc.$19
  • Amgen$18
  • Organogenesis Inc.$16
  • plus $23 from 2 others

What the payments were for

  • Food & beverage$162100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

20
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$162 in reported general payments places this provider in the 30th percentile of 981 family medicine providers in Nebraska.

See all family medicine providers in Nebraska

Medicare billing

Part B allowed, 2024
$21,105
Medicare patients
70
Services billed
324

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban209$129,190
MounjaroTirzepatide80$97,257
MyrbetriqMirabegron54$24,647
JardianceEmpagliflozin14$18,998
OzempicSemaglutide11$10,273
GemtesaVibegron26$8,675
Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog22$6,352
FarxigaDapagliflozin Propanediol11$6,284
LinzessLinaclotide11$6,063
SymbicortBudesonide/Formoterol Fumarate26$5,823
Fiasp FlextouchInsulin Aspart (Niacinamide)12$5,643
Serevent DiskusSalmeterol Xinafoate12$5,274
PremarinEstrogens, Conjugated12$5,232
Potassium Chloride258$4,499
Duloxetine Hcl130$4,346

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro$42$97,25780 claims
Astellas Pharma US IncMyrbetriq$13$24,64754 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 30th percentile of 981 family medicine providers in Nebraska.

Other family medicine in Creighton

See the full list for Nebraska

Where these figures come from

Is this you, or does something look wrong? →